Case Study  ·  Technology Scouting

Tracking variants beyond the clinic.

A global biopharmaceutical company wanted better ways to track viral variants for flu and COVID vaccine design. We landscaped emerging data sources, including wastewater sequencing, and connected the client with academic experts.

The Client

The client is a global biopharmaceutical company that develops vaccines. It wanted new variant tracking methods to improve flu and COVID vaccine development.

The Challenge

Strain testing alone.
Look further.

Prescouter was asked to identify emerging methodologies for viral variant tracking and surveillance, including innovation sources and technologies built on wastewater and environmental sequence data.

  • Sources

    New sequence data

    Beyond public sequence databases.

  • Environment

    Wastewater signals

    Tracking variants in the community.

  • Partners

    Academic experts

    Groups open to collaboration.

Our Approach

Landscaping new sources, then reaching out.

Landscape scan
Globaldata sources reviewed

Scan the field

We mapped new and emerging sequence data sources that could improve flu and COVID strain selection.

Academic outreach
Directstakeholder contact

Reach the experts

We contacted high-interest academic groups to gauge their interest in working with the client.

Introductions
3experts introduced

Make the connection

We introduced the client to experts working on viral variant tracking and surveillance.

The Outcome

Introductions to three variant experts.

Prescouter landscaped emerging sequence data sources for flu and COVID strain identification, including wastewater and environmental approaches. Targeted outreach to academic stakeholders then ended with introductions to 3 experts working on viral variant tracking and surveillance.

  • Landscape

    Emerging data sources

    For better strain identification.

  • Methods

    Wastewater sequencing

    Environmental signals of variants.

  • Network

    3 expert introductions

    In variant tracking and surveillance.

Vaccine design is only as good as its view of circulating strains. New data sources can widen that view.

Let’s Talk

Where could better data sharpen your R&D?

Find the data sources and the experts that move your research forward. Wherever you’re starting from, we’ll help you get there.

Or email [email protected]

Book a Session

Want to skip the email back-and-forth?

Pick a time on our calendar right now.

If you’d like to know the outcome of your submission, please leave your email address